Latest Market Access News

FirstWave’s Q3 FY25 update reveals steady contract renewals alongside tighter cash reserves, as the cybersecurity firm advances strategic partnerships and operational efficiencies.

Little Green Pharma reported a robust 40% revenue increase for FY25, driven by strong European sales and the strategic acquisition of Health House. The company also advanced clinical research and secured new therapy funding, positioning itself for continued growth.

Woodside Energy has inked a pivotal long-term agreement with bp to supply up to 640 billion cubic feet of natural gas for its Louisiana LNG project starting in 2029, marking a significant step in the project's development and environmental commitments.

Adherium Limited reports a surge in US commercial patients for its Hailie Smartinhaler platform, alongside strategic hires and a new product launch compatible with AstraZeneca inhalers, underpinning plans for a capital raise.

Microba Life Sciences reported robust Q3 FY25 growth in its microbiome diagnostic tests, led by MetaXplore and MetaPanel, while advancing its therapeutics pipeline and projecting strong full-year revenue growth.

Microba Life Sciences reports robust growth in microbiome diagnostic testing across Australia and the UK, while advancing US market entry plans and transitioning its Therapeutics business to a partnering model.

Nagambie Resources reported significant new antimony-gold intersections at its Nagambie Mine and joined a US Department of Defence consortium, positioning itself amid soaring antimony prices and strategic demand. The company also advanced funding arrangements and plans a resource update in the June quarter.

Wide Open Agriculture has inked an exclusive 18-month distribution agreement with Univar Solutions China to market its lupin protein products, marking a strategic push into the lucrative Chinese plant-based protein sector.

Bio-Gene Technology Limited has been awarded two significant grants totaling A$3 million by the US Department of Defense, validating its innovative insecticide technologies Flavocide® and Qcide®. The company is advancing regulatory filings and scaling production to target both military and civilian markets.

Energy Metals Limited has reported a 12% increase in uranium resources at its flagship Bigrlyi Joint Venture, strengthening its position amid a stable uranium market and robust cash reserves. The company is advancing exploration plans across its Northern Territory and Western Australia projects for 2025.

OncoSil Medical has reported a remarkable 233% increase in dose sales for Q3 FY25, alongside significant regulatory approvals and strategic expansions that position the company for accelerated growth.

Volt Resources Limited reports strong quarterly progress in graphite production and downstream development, securing new orders and partnerships while advancing US refinery plans and implementing cost-saving measures.